跳至主要内容
临床试验/NCT07310407
NCT07310407尚未招募2 期

Evaluation of the Effect of Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Ain Shams University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年1月1日最近更新:
干预措施

试验速览

阶段
2 期
状态
尚未招募
入组人数
120
试验地点
1
主要终点
• Change in tumor necrosis factor-alpha (TNF-α) levels from baseline to week 12.

研究概览

简要总结

暂无简介。

详细描述

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a common liver disorder with risks of progression to fibrosis, cirrhosis, and hepatocellular carcinoma.

Its global prevalence is high, driven by oxidative stress and impaired antioxidant defenses, while no approved pharmacological treatments currently exist. Nutritional agents such as vitamin C and rutin show promise in improving liver function and reducing oxidative damage.

This study will evaluate their combined effects in addressing MASLD's multifactorial pathology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of Metabolic-Associated Steatotic Liver Disease (MASLD).

排除标准

  • HCV infection.
  • HBV infection.
  • Patients with a history of significant alcohol consumption.
  • Autoimmune hepatitis.
  • Celiac disease (CD).
  • Wilson's disease (WD).
  • Haemochromatosis.
  • Drugs: Tamoxifen, Valproic acid, Amiodarone, Methotrexate, steroids and immunosuppressive agents, oral contraceptive pills, or drugs that can affect liver profile.
  • Hypo or hyper thyroidism.
  • Bypass surgeries.
  • TPN (Total Parenteral Nutrition).
  • Pregnant individuals or patients planning to become pregnant.

研究组 & 干预措施

Ruta C group

Experimental

Drug: Rutin + Vitamin C - Oral, two tablets containing 60 mg Rutin + 160 mg Vitamin C, three times daily for 12 weeks, plus lifestyle intervention (Mediterranean diet and structured exercise).

干预措施: Rutin + Vitamin C (Drug)

结局指标

主要结局

• Change in tumor necrosis factor-alpha (TNF-α) levels from baseline to week 12.

时间窗: 12 weeks

Serum TNF-α, a key biomarker of inflammation in MASLD

次要结局

  • • Change in serum malondialdehyde (MDA) levels from baseline to week 12.(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaimaa salem

Ain Shams University

Ain Shams University

研究点 (1)

Loading locations...

相似试验